Ronald Ellis
Corporate Officer/Principal chez Pacira Pharmaceuticals, Inc. (California)
Fortune : 937 470 $ au 31/05/2024
Profil
Ronald J.
Ellis is currently a Vice President at Pacira Pharmaceuticals, Inc. He was previously an Independent Director at TELA Bio, Inc. from 2018 to 2020.
He also held positions as a Principal at Wyeth LLC, ABN AMRO Securities (USA), Inc., and Senior Vice President at Leerink Partners LLC.
Ellis received an undergraduate degree and an MBA from St. Joseph's University and a doctorate from Philadelphia College of Osteopathic Medicine.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
PACIRA BIOSCIENCES, INC.
0,07% | 07/06/2023 | 30 909 ( 0,07% ) | 937 470 $ | 31/05/2024 |
Postes actifs de Ronald Ellis
Sociétés | Poste | Début |
---|---|---|
Pacira Pharmaceuticals, Inc. (California)
Pacira Pharmaceuticals, Inc. (California) Medical SpecialtiesHealth Technology Pacira Pharmaceuticals, Inc. develops and manufactures injectable and sustained release therapeutic products. It focuses on clinical and commercial development activities by understanding the needs of the acute care market. The company was founded in March 2007 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01/10/2016 |
Anciens postes connus de Ronald Ellis
Sociétés | Poste | Fin |
---|---|---|
TELA BIO, INC. | Directeur/Membre du Conseil | 20/04/2020 |
ABN AMRO Securities (USA), Inc. | Corporate Officer/Principal | 31/08/2002 |
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Corporate Officer/Principal | - |
Leerink Partners LLC
Leerink Partners LLC Investment Banks/BrokersFinance Leerink Partners LLC is a full-service brokerage and investment banking firm headquartered in Boston, Massachusetts. The firm was founded by Jeffrey Leerink in 1995 and formerly known as SVB Securities LLC. They rebranded as Leerink Partners in 2023. The firm is a subsidiary of SVB Securities LLC. Leerink Partners provides institutional sales, equity research, institutional trading, and corporate finance and asset management services to the healthcare and technology industries. They offer superior execution capabilities in common stock, convertibles and derivatives with a singular focus on healthcare and a knowledge-led approach. | Analyst-Equity | - |
Formation de Ronald Ellis
St. Joseph's University | Masters Business Admin |
Philadelphia College of Osteopathic Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
TELA BIO, INC. | Health Technology |
Entreprise privées | 4 |
---|---|
Leerink Partners LLC
Leerink Partners LLC Investment Banks/BrokersFinance Leerink Partners LLC is a full-service brokerage and investment banking firm headquartered in Boston, Massachusetts. The firm was founded by Jeffrey Leerink in 1995 and formerly known as SVB Securities LLC. They rebranded as Leerink Partners in 2023. The firm is a subsidiary of SVB Securities LLC. Leerink Partners provides institutional sales, equity research, institutional trading, and corporate finance and asset management services to the healthcare and technology industries. They offer superior execution capabilities in common stock, convertibles and derivatives with a singular focus on healthcare and a knowledge-led approach. | Finance |
ABN AMRO Securities (USA), Inc. | Finance |
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Health Technology |
Pacira Pharmaceuticals, Inc. (California)
Pacira Pharmaceuticals, Inc. (California) Medical SpecialtiesHealth Technology Pacira Pharmaceuticals, Inc. develops and manufactures injectable and sustained release therapeutic products. It focuses on clinical and commercial development activities by understanding the needs of the acute care market. The company was founded in March 2007 and is headquartered in San Diego, CA. | Health Technology |